Healthcare investors keeping an eye on ‘two sessions’ for clarity on drug pricingMarch 4, 2026 🔥 Trending
Hong Kong-listed Chinese drug firms set to turn corner on rising sales, licensing dealsMarch 1, 2026 🔥 Trending